Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
CA Stock MarketDetailed Quotes
BCT BriaCell Therapeutics Corp
- 6.910
- -0.350-4.82%
15min DelayMarket Closed Apr 28 16:00 ET
25.63MMarket Cap-1.00P/E (TTM)
7.240High6.590Low21.94KVolume6.910Open7.260Pre Close151.36KTurnover49.05052wk High0.69%Turnover Ratio3.71MShares4.33052wk Low-6.909EPS TTM22.11MFloat Cap10091.250Historical HighLossP/E (Static)3.20MShs Float4.330Historical Low-6.006EPS LYR8.95%Amplitude--Dividend TTM5.13P/B1Lot Size--Div YieldTTM
BriaCell Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.06%7.17M | -39.40%5.15M | 43.22%33.33M | -25.15%5.77M | 62.58%9.23M | 119.10%9.83M | 57.37%8.5M | 52.25%23.27M | 47.22%7.71M | 37.68%5.68M |
| Selling and administrative expenses | -5.56%1.48M | -9.62%1.49M | -22.47%6.15M | -46.32%1.36M | -13.46%1.57M | 9.70%1.57M | -23.38%1.65M | 9.19%7.94M | 22.91%2.54M | -2.05%1.82M |
| -General and administrative expense | -5.56%1.48M | -9.62%1.49M | -22.47%6.15M | -46.32%1.36M | -13.46%1.57M | 9.70%1.57M | -23.38%1.65M | 9.19%7.94M | 22.91%2.54M | -2.05%1.82M |
| Research and development costs | -31.16%5.68M | -46.55%3.67M | 77.21%27.18M | -14.75%4.41M | 98.36%7.66M | 170.44%8.26M | 110.65%6.86M | 91.19%15.34M | 63.07%5.17M | 70.16%3.86M |
| Operating profit | 27.06%-7.17M | 39.40%-5.15M | -43.22%-33.33M | 25.15%-5.77M | -62.58%-9.23M | -119.10%-9.83M | -57.37%-8.5M | -52.25%-23.27M | -47.22%-7.71M | -37.68%-5.68M |
| Net non-operating interest income (expenses) | -42.60%46.83K | -93.16%13.05K | -67.68%288.02K | -100.00%2 | -93.84%15.61K | -66.09%81.6K | 1.31%190.82K | 556.50%891.21K | 153.50%208.78K | 604.39%253.49K |
| Non-operating interest income | -42.60%46.83K | -93.16%13.05K | -67.68%288.02K | -100.00%2 | -93.84%15.61K | -66.09%81.6K | 1.31%190.82K | 551.80%891.21K | 153.50%208.78K | 604.39%253.49K |
| Other net income (expenses) | 149.48%784.78K | -104.83%-689.49K | 1,252.34%28.11M | -11.01%4.52M | 1,965.18%10.91M | 79.23%-1.59M | 247.38%14.27M | 117.78%2.08M | 8.02%5.08M | 108.91%528.1K |
| Gain on sale of security | 152.78%827.37K | -104.33%-617.98K | 1,257.46%28.22M | -10.00%4.57M | 1,972.18%10.94M | 79.47%-1.57M | 247.38%14.27M | 117.78%2.08M | 8.02%5.08M | 108.91%528.1K |
| Income before tax | 44.08%-6.34M | -197.83%-5.83M | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 44.08%-6.34M | -197.83%-5.83M | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M |
| Net income continuous operations | 44.08%-6.34M | -197.83%-5.83M | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M |
| Noncontrolling interests | -18.07%-46.41K | 36.49%-27.1K | -140.08K | -34.59K | -23.52K | -39.31K | -42.67K | 0 | 0 | 0 |
| Net income attributable to the company | 44.30%-6.29M | -196.68%-5.8M | 76.40%-4.79M | 49.80%-1.21M | 135.05%1.72M | 4.94%-11.29M | 642.37%6M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 44.30%-6.29M | -196.68%-5.8M | 76.40%-4.79M | 49.80%-1.21M | 135.05%1.72M | 4.94%-11.29M | 642.37%6M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M |
| Diluted earnings per share | 78.10%-2.33 | -157.89%-3.3 | 77.69%-4.35 | 53.33%-1.05 | 134.38%1.65 | 7.88%-10.64 | 642.86%5.7 | 24.86%-19.5 | -400.00%-2.25 | 50.77%-4.8 |
| Basic earnings per share | 78.10%-2.33 | 56.00%-3.3 | 77.69%-4.35 | 53.33%-1.05 | 134.38%1.65 | 7.88%-10.64 | -614.29%-7.5 | 24.86%-19.5 | -400.00%-2.25 | 50.77%-4.8 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts?